loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 2284863 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ALGLUCOSIDASE ALFA (1)

filter

01 SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC (1)

filter

01 POWDER FOR SOLUTION (1)

filter

01 50MG/VIAL (1)

filter

01 Canada (1)

URL Supplier Web Content
POWDER FOR SOLUTION
50MG/VIAL
MYOZYME
Canada
2284863
10.3ML
Prescription
Sanofi Company Banner

Cophex 2024

Not Confirmed

envelop Contact Supplier

Looking for CTD TGA MCC DOSSIER APPLICATION 2284863

Looking for CTD TGA MCC DOSSIER APPLICATION 2284863 1

19

Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

One of their notable products is ALGLUCOSIDASE ALFA, with a corresponding application number 2284863 and regulatory information .

proudly manufactured in the

Sanofi's MYOZYME POWDER FOR SOLUTION, medication with 50MG/VIAL of ALGLUCOSIDASE ALFA.

Post Enquiry
POST ENQUIRY